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Abstract
Background: To examine the influence of cigarette, cigar and pipe smoking, cessation of cigarette smoking and
passive smoke exposure on the risk of pancreatic cancer.
Methods: Exposure data were collected during in-person interviews in a population-based case-control study of
pancreatic cancer (N = 532 cases, N = 1701 controls) in the San Francisco Bay Area. Odds ratios (ORs) were
adjusted for potential confounders.
Results: The adjusted odds ratio (OR) of pancreatic cancer among current smokers was 1.9 (95% confidence
interval (CI), 1.4-2.7). A significant, positive trend in risk with increasing pack-years of smoking was observed
(P-trend <0.0001). Compared with participants who continued to smoke, former smokers had no statistically
significant elevation in risk of pancreatic cancer 10 years after smoking cessation, with risk reduced to that of never
smokers regardless of prior smoking intensity. Both men and women experienced similar increased risk of
pancreatic cancer with increasing smoking duration. Cigar and pipe smoking and exposure to passive smoke were
not associated with pancreatic cancer.
Conclusions: Cigarette smoking is associated with an increased risk of pancreatic cancer. Smokers who had quit
for ≥10 years no longer experienced an increased risk. Future work will help to determine the effect of declining
smoking rates on pancreatic cancer incidence.
Background
Pancreatic cancer is the fourth leading cause of death
from cancer among men and women in the United
States and is expected to result in 43,140 new cases and
36,800 deaths in 2010 [1]. Due to its aggressiveness and
a lack of early detection methods, pancreatic cancer is
often metastatic in patients at the time of diagnosis
resulting in a 5-year relative survival rate for all stages
of <5%. The incidence of pancreatic cancer varies by
age, sex, and race - and survival differences by race have
been observed [2-6].
Of the several modest risk factors that have been iden-
tified for pancreatic cancer, including obesity, diabetes,
physical inactivity, chronic pancreatitis and dietary
factors [7-12], cigarette smoking has been reported most
consistently [2,13-17]. In a large meta-analysis [14] cur-
rent cigarette smoking was associated with an overall
relative risk (RR) of pancreatic cancer of 1.7 whereas
current cigar and pipe smoking was associated with an
approximate RR of 1.5. There was evidence of a dose-
response relationship between smoking and pancreatic
cancer [14] although the risk for those who had quit
for10 or more years was not different from that of
nonsmokers [14]. A recent pooled analysis from the
Pancreatic Cancer Cohort Consortium [17] identified an
odds ratio (OR) of 1.8 for current cigarette smoking and
that risk was similar to that for never smokers after
more than 15 years of smoking cessation.
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cases in the United States are related to cigarette smok-
ing [18,19]. Because of their public health implications,
the effects of smoking cessation on pancreas cancer risk
are important to understand. In the present population-
based, case-control study of pancreatic cancer we exam-
ined cigarette, cigar and pipe smoking as risk factors for
pancreas cancer. We quantified the relationship between
cigarette smoking and pancreatic cancer and estimated
the effects of smoking duration, pack-years smoked,
cigarettes smoked/day and cigarette smoking cessation
on risk of developing pancreatic cancer. Lastly, we
assessed the effects of passive cigarette smoke exposure
on the risk of pancreatic cancer.
Methods
Study Participants
Detailed methods for this case-control study have been
published [20-24]. Briefly, a population-based case-con-
trol study of pancreatic cancer was conducted in six San
Francisco Bay Area counties (Alameda, Contra Costa,
Marin, San Francisco, San Mateo, and Santa Clara).
Cases with primary adenocarcinoma of the exocrine
pancreas were identified using rapid case ascertainment
by the Northern California Cancer Center (Union City,
CA) with a goal to identify patients in the study area
within one month of diagnosis. Eligible cases were
newly diagnosed between 1995 and 1999 with adenocar-
cinoma of the exocrine pancreas who were between 21
and 85 years old, resided in one of the six Bay Area
counties listed above, were alive at the time of the first
attempted contact, and could complete an interview in
English. There were 65 out-of-area pancreatic cancer
patients identified through clinical records at the UCSF
Medical Center who were eligible to participate because
they met all study criteria other than their place of resi-
dence at the time of diagnosis. Diagnoses for out-of-area
patient participants were confirmed using patients’
pathology reports and medical records. A total of 532
eligible cases completed the interview for a 67%
response rate. The refusal rate was 8% among cases. No
eligible patients with completed interviews were
excluded from this analysis. Patient diagnoses were
confirmed by participants’ physicians and by the Surveil-
lance, Epidemiology, and End Results abstracts that
included histologic confirmation of disease.
Control participants for the in-area cases were identi-
fied within the six San Francisco Bay Area counties
using random-digit dial (RDD), and were frequency-
matched to cases by sex and 5-year age group in an
approximate 3:1 ratio. Eligibility criteria were identical
for case and control participants except for pancreatic
cancer status. Control identification for those >65 years
of age was supplemented by random selection from
Health Care Finance Administration lists (now the
Centers for Medicare and Medicaid Services) for the six
Bay Area counties. Out-of-area controls also were iden-
tified by RDD, were frequency matched to out-of-area
c a s e sb yr e s i d e n t i a lt e l e p h o n ea r e ac o d ea n dp r e f i x ,a n d
by sex and 5-year age group. A total of 1,701 eligible
control participants completed the study interview for a
67% response rate [21]. The refusal rate among controls
was 9%.
Interviews
Detailed in-person interviews were conducted in the
homes of the participants or at a location of their choice
for Bay Area participants and by telephone interview for
out-of-area participants. No proxy interviews were con-
ducted. The University of California San Francisco
Committee on Human Research approved the study
protocols and procedures. Written informed consent
was obtained from each study participant before inter-
view. Primary topics included on the questionnaire
were: demographic factors, detailed job and occupational
history, use of tobacco products and alcohol consump-
tion, medical history including allergies, diabetes, pan-
creatitis and gallbladder disease, family medical history,
anthropometric data and a detailed assessment of diet
including average consumption of specific foods, vitamin
supplement use and dietary modifications.
Race/ethnicity was based on self-report and was
broadly defined as Caucasian, black/African-American,
Asian, and Hispanic (black or white). Nine cases and 33
controls who were of mixed race/ethnicity were classified
as “other race/ethnicity” for these analyses. Participants
were defined as smokers if they had smoked >100 cigar-
ettes in their lifetime. Former smokers were defined as
those who had ceased smoking one year or more prior to
diagnosis or interview. Those who had quit less than one
year prior to diagnosis/interview were considered current
smokers. Participants were considered cigar and/or pipe
smokers if they had ever smoked pipes and/or cigars for
>6 months. Body mass index (BMI; weight in kilograms
divided by height in meters squared) was based on
self-reported height and usual adult weight and was
categorized based on quartiles of the distribution among
controls by sex as follows: men: <23.1; 23.1-<25.1;
25.1-<27.1; >27.1 kg/m
2; and women: <21.5; 21.5-<23.4;
23.4-<25.8; >25.8 kg/m
2. Participants were defined as
consumers of alcohol if they had ever had at least one
alcoholic drink per month.
Statistical analysis
Unconditional logistic regression was used to obtain
odds ratios (ORs) as estimates of relative risks (hereafter
called risk) and 95% confidence intervals (CIs). All
models were adjusted for age in 5-year groups, sex,
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ethnicity (Hispanic white, non-Hispanic white, black or
African-American, Asian, other), diabetes diagnosis,
pancreatitis diagnosis, gallbladder disease (gallstones or
gallbladder inflammation), alcohol intake and BMI
[24-28]. Models for cigar/pipe smoking and passive
smoke exposure were further adjusted for cigarette
smoking status (never, past and current). In the com-
bined analysis of smoking intensity and years of smok-
ing cessation, similarity of ORs was tested using the
Breslow-Day test for homogeneity.
Results
A total of 532 cases and 1,701 control participants com-
pleted the interview. There were 16 cases and 73 con-
trols who reported smoking cigars or pipes but not
cigarettes leaving a total of 516 cases and 1628 controls
who were included in the final analyses of cigarette
smoking. Distribution by age, education level, race, eth-
nicity, sex, BMI, diabetes diagnosis, pancreatitis diagno-
sis, gallbladder problems and alcohol intake for total
pancreas cancer cases and controls are presented in
Table 1. The mean age for pancreas cancer cases and
control participants was 65 and 64 years, respectively. In
general, cases were somewhat less educated and a
greater proportion were men, black, had a high BMI
(men only) and were more likely to have been diagnosed
with diabetes, pancreatitis or gallbladder disease.
Smoking Status and Quantity
The OR for current smokers was 1.9 compared with
never smokers (Table 2). Risk increased with increasing
intensity of smoking that was assessed in three ways, as
the number of cigarettes smoked per day, years smoked,
and pack-years smoked (Table 2). Compared with non-
smokers, participants who smoked for at least 40 years
h a da nO Ro f1 . 8a n dt h o s ew h os m o k e da tl e a s t4 0
pack-years had an OR of 2.0. Analyses by sex and
restricted race/ethnicity showed that men (p = 0.004)
and women (p = 0.009) from all races/ethnicities, and
that non-Hispanic whites (p = 0.0002) experienced
increased risk with increasing duration smoked (data
not shown). Smoking 40 or more years was associated
with similar increases in risk for men (OR = 1.8, 95%CI
= 1.2-2.9), women (OR = 1.8, 95%CI = 1.2-2.7) and
non-Hispanic white men and women (OR = 1.8, 95%CI
= 1.3-2.6) (data not shown). Sample sizes were too small
to examine associations with cigarette smoking among
other race and ethnicity groups. Smoking at least one
cigar or pipe per month for over six months was not
associated with pancreatic cancer (Table 2).
Table 1 Characteristics of pancreatic cancer (PanCA)
cases and controls in a population based study in the
San Francisco Bay Area
PanCA Controls
Characteristic N = 532 N = 1701
Age (years) Mean (s.d.) 65 (11) 64 (11)
Education (years) n (%) n (%)
1-12 235 (44) 534 (31)
12-16 200 (38) 754 (44)
Over 16 97 (18) 413 (24)
Race/ethnicity
White, non-Hispanic 417 (78) 1357 (80)
White, Hispanic 25 (5) 114 (7)
Black 46 (9) 78 (5)
Asian 35 (7) 119 (7)
Other 9 (2) 33 (2)
Sex
Men 291 (55) 883 (52)
Women 241 (45) 818 (48)
Usual adult BMI
Men <23.1 48 (17) 222 (25)
23.1-<25.1 70 (24) 223 (25)
25.1-<27.1 75 (26) 214 (24)
27.1+ 95 (33) 221 (25)
Women <21.5 67 (28) 197 (24)
21.5-<23.4 51 (21) 208 (26)
23.4-<25.8 62 (26) 208 (26)
25.8+ 61 (25) 198 (24)
Diabetes diagnosis
Yes 69 (13) 152 (9)
No 455 (87) 1538 (91)
Pancreatitis diagnosis
Yes 37 (7) 19 (1)
No 491 (93) 1681 (99)
Gallstones or
gallbladder
inflammation
Yes 95 (18) 207 (12)
No 432 (82) 1493 (88)
Alcohol (ever had at
least one alcoholic
drink per month)
Yes 447 (84) 1396 (82)
No 85 (16) 305 (18)
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The effects of smoking cessation were examined in
mutually exclusive groups according to smoking dura-
tion (Table 3). Former smokers who quit ≥10 years
prior to diagnosis or interview had an OR similar to
that of nonsmokers (OR = 0.99, 95% CI = 0.77-1.3; data
not in tables) whereas for former smokers who quit ≤10
years ago the OR was 1.6 (95% CI = 1.1-2.3). Relative to
current smokers, risk diminished among former smokers
who had quit 10-<15 years prior to diagnosis or inter-
view. Former smokers who had quit for ≥15 years had
no elevated risk of pancreatic cancer. We also
conducted dichotomized analyses that were stratified by
years since quitting to assess whether duration of cessa-
tion (<10 years, ≥10 years) modified the effect of lifetime
or daily cigarette consumption on risk of pancreatic can-
cer (Table 4). Former smokers who quit ten or more
years prior to diagnosis or interview had an OR similar
to that of nonsmokers regardless of prior smoking
intensity (Table 4). However, the effect of smoking ces-
sation among those who quit fewer than ten years prior
to diagnosis or interview varied somewhat by prior
smoking intensity when compared to nonsmokers
(Table 4). For example, the risk of pancreatic cancer for
those who smoked for 40 or more years was similar to
current smokers (OR = 1.8), but not for those who had
smoked fewer than 40 years (OR = 1.3). However, confi-
dence limits overlapped and tests for homogeneity
showed that the estimated ORs were similar by smoking
intensity or time of cessation (Table 4).
Table 2 Odds Ratios (OR) and 95% confidence intervals (CI) for pancreatic cancer (PanCA) associated with smoking
status, intensity and duration, San Francisco Bay Area, California
PanCA
a Controls
a
N = 532 N = 1701 OR (95% CI)
b
n (%) n (%)
Never smoked 163 (32) 650 (40) 1.0 (Ref.)
Cigarette Smoking
Former smoker
c 241 (47) 781 (48) 1.1 (0.87 - 1.4)
Current smoker
d 112 (22) 197 (12) 1.9 (1.4 - 2.7)
P-trend 0.0002
Ever smoked cigars and/or pipes
e 100 (19) 334 (32) 0.88 (0.66 - 1.2)
Average cigarettes/day
<20 194 (38) 608 (37) 1.2 (0.92 - 1.5)
20-<40 137 (27) 329 (20) 1.4 (1.0 - 1.9)
40+ 22 (4) 41 (3) 1.8 (0.99 - 3.1)
P-trend 0.008
Years smoked
<20 177 (34) 637 (39) 0.9 (0.68 - 1.7)
20-<40 64 (12) 144 (9) 1.3 (0.98 - 1.7)
40+ 112 (22) 197 (12) 1.8 (1.3 - 2.4)
P-trend 0.0001
Pack years
<20 129 (25) 487 (30) 1.1 (0.81 - 1.4)
20-<40 110 (21) 310 (19) 1.2 (0.90 - 1.6)
40+ 114 (22) 181 (11) 2.0 (1.5 - 2.8)
P-trend <.0001
a The number of participants may vary because of missing data.
b Adjusted for: age, education, race, ethnicity, diabetes, pancreatitis, gallbladder disease, alcohol intake and body mass index.
c Includes smokers who quit ≥1 year prior to diagnosis/interview.
d Includes former smokers who quit within the immediate 1 year prior to interview.
e Includes cigar and pipe smokers who also smoked cigarettes and 16 cases and 73 controls who were cigar and/or pipe smokers who did not smoke
cigarettes.
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Passive exposure to household and workplace smoke
was not associated with an increased risk of pancreatic
cancer (Table 5). Childhood household exposure (OR =
0.99), adult household exposure (OR = 1.2) and work-
place (OR = 1.1) exposure were not associated with an
increased risk of pancreatic cancer after adjustment for
smoking behavior (never, past, current). The categories
are not mutually exclusive, which allowed for the exami-
nation of exposure to multiple exposure environments
(e.g. exposure at home and work). Analysis of mutually
exclusive exposure environments (e.g. exposure at either
home or work) did not yield significant associations
with pancreatic cancer risk (data not shown).
Discussion
The results from this population-based case-control
study expand upon those of earlier case-control and
cohort studies that have demonstrated the association
between smoking and pancreatic cancer risk. The cur-
rent estimation of the overall risk of pancreatic cancer
among current smokers is consistent with the 1.6- to
1.9-fold increased risk reported by other investigators
[14]. Our results support previous work that has
identified a relationship between smoking intensity and
duration and pancreatic cancer [14,17]. After adjustment
for potential confounders and suspected risk factors, we
observed a two-fold increased risk of pancreatic cancer
among those who smoked 40 or more pack years and
similarly elevated risks were observed for those who had
smoked for more than 40 years or more than 40 cigar-
ettes per day. Unlike previous studies reporting stronger
smoking-related associations among women than among
men [9,29,30], we observed similar risks for women and
men. In contrast to a recent meta-analysis [14], we did
not observe an increased risk of pancreatic cancer
among current cigar and/or pipe smokers. However,
limited sample size restricted our examinations to parti-
cipants who ever smoked pipes and cigars and who also
smoked cigarettes.
The effects of smoking cessation in our study popula-
tion also were similar to previously reported results
[14,17]. In the current study, the risk estimate among
former smokers who quit 10 years prior to diagnosis or
interview was similar to the decrease observed in the
meta-analysis of 82 published studies [14]. To eliminate
the combined effect of short and long-term duration of
years since quit, we expanded upon these analyses by
investigating duration of smoking cessation in mutually
exclusive groups. Our results showed that former smo-
kers who had quit fewer than 13 years prior to diagno-
sis or interview had a greater than 1.6 fold elevated risk
of pancreatic cancer. In contrast, former smokers who
had quit 10-<15 or ≥15 years prior to diagnosis or
Table 3 Odds Ratios (OR) and 95% confidence intervals
(CI) for pancreatic cancer (PanCA) associated with
cigarette smoking cessation, San Francisco Bay Area,
California.
PanCA
a Controls
a
N = 516 N = 1628 OR (95% CI)
b
n (%) n (%)
Never
smoked
163 (32) 650 (40) 1.0 (Ref.)
Years since last
smoked
c
>25 97 (19) 370 (23) 0.98 (0.72 - 1.3)
20-<25 25 (5) 89 (5) 0.92 (0.55 - 1.5)
15-<20 23 (4) 92 (6) 0.84 (0.5 - 1.4)
10-<15 33 (6) 87 (5) 1.2 (0.75 - 1.9)
<10 31 (6) 51 (3) 1.6 (1.1 - 2.3)
Current
smoker
d
112 (22) 197 (12) 1.9 (1.4 - 2.7)
a The number of participants may vary because of missing data.
b Adjusted for: age, education, race, ethnicity, diabetes, pancreatitis,
gallbladder disease, alcohol intake and body mass index.
c Includes smokers who quit ≥1 year prior to diagnosis/interview.
d Includes former smokers who quit within the immediate 1 year prior to
interview.
Table 4 Odds Ratios (OR) and 95% confidence intervals
(CI) for pancreatic cancer (PanCA) associated with
cigarette smoking cessation in relation to frequency of
use compared with nonsmokers, San Francisco Bay Area,
California.
Years since quitting
a
Lifetime Cigarette
Frequency
of Use
c
<10 >=10
OR (95% CI)
b OR (95% CI)
b
<40 years smoked 1.3 (0.81 - 2.2) 1.0 (0.76 - 1.3)
>=40 years smoked 1.8 (1.1 - 2.9) 0.99 (0.56 - 1.7)
Test for Homogeneity
d
(p-value)
0.29
<20 cigarettes/day 1.8 (1.2 - 2.8) 0.96 (0.71 - 1.3)
>= 20 cigarettes/day 1.3 (0.75 - 2.2) 1.0 (0.73 - 1.5)
Test for Homogeneity
d
(p-value)
0.26
<40 packyears 1.8 (1.1 - 2.8) 0.96 (0.73 - 1.3)
>= 40 packyears 1.4 (0.83 - 2.3) 1.2 (0.74 - 1.8)
Test for Homogeneity
d
(p-value)
0.45
a The number of participants may vary because of missing data.
b Compared with nonsmokers. Adjusted for: age, education, race, ethnicity,
diabetes, pancreatitis, gallbladder disease, alcohol intake and body mass
index.
c Includes smokers who quit ≥1 year prior to diagnosis/interview.
d Breslow-Day test.
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ferent from unity. Participants who had stopped smok-
ing for ten or more years prior to diagnosis or
interview had no increased risk of pancreatic cancer
relative to nonsmokers, regardless of prior smoking
intensity. In contrast, the effect of smoking cessation
among those who had quit fewer than ten years prior
to diagnosis or interview varied by prior smoking inten-
sity. These results are similar to those of a previous
study that examined the combined effects of smoking
cessation and prior smoking intensity [31]. Relative to
current smokers, a consistent reduction in risk was
observed for those former smokers who had quit for
fewer than 10 to at least 25 years (in 5-year mutually
exclusive groups).
Environmental tobacco smoke contains thousands of
chemicals including dozens of known carcinogens [32]
yet a link between passive or secondhand smoke expo-
sure and pancreatic cancer has not been established
[33,34]. In this study, passive exposure to household and
workplace cigarette smoke among adults was not asso-
ciated with an increased risk of pancreatic cancer, nor
was childhood household exposure. We may not have
expected to see an association with childhood or early
a d u l te x p o s u r et op a s s i v es m o k ed u et ot h el o n gt i m e
interval to cancer development. This is supported by
our results that demonstrate no increased risk for perso-
nal smoking after ten years of cessation.
Strengths of this study included the large sample size,
the population-based design, similarity of response rates
for the cases and controls, and the low case refusal rate
of 8 percent. The primary reason for lost patients was
aggressive disease and the high mortality rate of pan-
creatic cancer. Study design methods used to diminish
potential selection bias included random-digit-dial to
identify age-, sex- and county-matched controls from
the same population from where the cases were
obtained and rapid case ascertainment to identify all
incident pancreatic cancer cases diagnosed in six Bay
Area counties between 1994 and 1999. Trained experi-
enced interviewers who were unaware of the study
hypotheses conducted in-person interviews with partici-
pants to diminish interviewer bias and no proxy
interviews were conducted to diminish recall and mis-
classification bias. Several limitations also should be
considered when interpreting the results of this study.
In particular, as in all case-control investigations, there
may have been recall bias due to differential reporting
of past smoking by cases versus controls because smok-
ing could possibly have been known as a risk factor for
pancreatic cancer among some individuals. However,
cases and controls were equally likely to have quit
smoking, suggesting that the likelihood that the
observed associations were due to recall bias among the
cases was low. In addition, the eligible cases who had
died prior to interview may have been smokers dispro-
portionately to nonsmokers and this may have affected
the ORs resulting in bias toward the null. Multiple com-
parisons were made in this study, and some results
could have been due to chance. However, this study was
designed to test specific hypotheses related to smoking,
and the outcomes of the analyses were generally consis-
tent with previous studies supporting a causative role of
cigarette smoking for pancreatic cancer.
Conclusions
These data support evidence that cigarette smoking is
a risk factor for pancreatic cancer. This investigation
reinforces the results of earlier studies by demonstrat-
ing the benefits of smoking cessation on risk of pan-
creatic cancer and extends the earlier reports by:
quantifying the relationship between cigarette smoking
intensity and pancreatic cancer; estimating the modify-
ing effects of smoking cessation by smoking duration,
pack-years smoked, and cigarettes smoked per day on
risk of developing pancreatic cancer; and assessing the
effects of cigar and pipe smoking and passive cigarette
smoke exposure on the risk of pancreatic cancer.
T h e s ed a t aa l o n gw i t ht h er e s u l t sf r o mp r e v i o u s
studies suggest that future work should focus on the
effect that declining smoking rates will have on pan-
creatic cancer incidence.
Table 5 Odds Ratios (OR) and 95% confidence intervals
(CI) for pancreatic cancer (PanCA) associated with passive
exposure to cigarette smoke, San Francisco Bay Area,
California.
PanCA
a Controls
a
n (%) n (%) OR (95% CI)
b
Childhood household
exposure
c
Never 230 (43) 758 (45) 1.0 (Ref.)
Ever 301 (57) 940 (55) 0.99 (0.80 - 1.2)
Adulthood household
exposure
c
Never 239 (45) 888 (52) 1.0 (Ref.)
Ever 293 (55) 813 (48) 1.2 (0.96 - 1.5)
Adulthood workplace
exposure
c
Never 232 (45) 827 (48) 1.0 (Ref.)
Ever 293 (55) 874 (45) 1.1 (0.86 - 1.3)
a The number of participants may vary because of missing data
b Adjusted for: age, education, race, smoking status (never, former, current),
ethnicity, diabetes, pancreatitis, gallbladder disease, alcohol intake and BMI
adjusted
c Exposure environments are not mutually exclusive (i.e. participants could
have been exposed in multiple environments)
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